Codiak Biosciences Inc. (CDAK) PT Raised to 'Street High' $31 at Wedbush Following Data
Tweet Send to a Friend
Wedbush analyst David Nierengarten raised the price target on Codiak Biosciences Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
